Skip to main content

Protein kinases in human breast cancer

Summary

The family of protein kinases includes many oncogenes and growth factor receptors, many of which have been linked to the pathogenesis and progression of cancer. Protein tyrosine kinases such as HER-2/c-erbB-2 and the epidermal growth factor receptor (EGFR) have been linked specifically to breast cancer, and perturbations of HER-2 affect response to chemotherapy. We have reviewed the biology of protein kinases in human breast cancer, as well as their translational applications to breast cancer patients. We have studied the spectrum of protein kinases expressed in human breast cancer cells and have identified four protein kinases with potentially important functions in breast cancer:rak (src-related), TK5 (which we now designate JAK3), the focal adhesion kinase (FAK), and STK1 (human M015/CAK). We describe the potential significance of these genes in breast cancer, as well as our methodology for identifying and characterizing novel genes in breast cancer.

This is a preview of subscription content, access via your institution.

References

  1. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G: Structural organization of thebcr gene and its role in the Ph1 translocation. Nature 315:758–761, 1985.

    Google Scholar 

  2. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G: PTC is a novel rearranged form of theret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557–563, 1990.

    Google Scholar 

  3. Slamon DJ, Godolphin W, Jones LA, et al: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712, 1989.

    Google Scholar 

  4. Tripathy D, Benz CC: Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.In: Benz CC, Liu ET (eds) Cancer Treatment and Research: Oncogenes and Tumor Suppressor Genes in Human Malignancies. Kluwer, Norwell, 1993, pp 15–60.

    Google Scholar 

  5. van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R: Neu protein overexpression in breast cancer. Association with comedotype ductal carcinomain situ and limited prognostic value in stage II breast cancer. N Engl J Med 391: 1239–1245, 1988.

    Google Scholar 

  6. Liu E, He M, Barcos M, Thor A, Benz CC: High frequency of HER-2/neu amplification inin situ carcinoma of the breast: Analysis using differential polymerase chain reaction. Oncogene 7:1027–1032, 1992.

    Google Scholar 

  7. Soomro S, Shousha S, Taylor P, Shepard HM, Feldmann M: c-erbB2 expression in different histologic types of invasive carcinoma. J Clin Path 44:211–214, 1991.

    Google Scholar 

  8. Olsson H, Borg A, Ferno M, Ranstam J, Sigurdsson H: Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones. J Natl Cancer Inst 83:1483–1487, 1991.

    Google Scholar 

  9. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53, 1990.

    Google Scholar 

  10. Bonneterre J, Peyrat JP, Beuscart R, Demaille A: Prognostic significance of insulin like growth factor I receptors in human breast cancer. Cancer Res 50: 6931–6935, 1990.

    Google Scholar 

  11. Johnston SR, Dowsett M, Smith IE: Towards a molecular basis for tamoxifen resistance in breast cancer. Ann Oncol 3:503–511, 1992.

    Google Scholar 

  12. Klijn JGM, Berns PM, Schimitz PI, Foekens JA: The clinical significance of epidermal growth factor receptor in human breast cancer. A review of 5232 patients. Endocrine Rev 13:3–17, 1992.

    Google Scholar 

  13. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC: Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121–1135, 1990.

    Google Scholar 

  14. Muss H, Thor A, Kute T, Liu ET, Koerner R, Berry D, Cirrincione C, Wood S, Barcos M, Henderson IC: c-erbB-2 expression and S-phase activity predict response to adjuvant therapy in women with node positive early breast cancer. New Engl J Med 330: 1260–1266,1994.

    Google Scholar 

  15. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr, Mendelsohn J: Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85:1327–1333, 1993.

    Google Scholar 

  16. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ: p185c-erbB-2 signaling enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. Cancer Res 54:3758–3765, 1994.

    Google Scholar 

  17. Cance WG, Craven RJ, Weiner TM, Liu ET: Novel protein kinases expressed in human breast cancer. Int J Cancer 54:571–577, 1993.

    Google Scholar 

  18. Simon MA, Drees B, Kornberg T, Bishop JM: The nucleotide sequence and the tissue-specific expression of Drosophila c-src. Cell 42:831–840, 1985.

    Google Scholar 

  19. Letwin K, Yee SP, Pawson T: Novel protein-tyrosine kinase cDNAs related tofps/fes andeph cloned using anti-phosphotyrosine antibody. Oncogene 3:621–627, 1988.

    Google Scholar 

  20. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci 90:8429–8433, 1993.

    Google Scholar 

  21. Hildebrand JD, Schaller MD, Parsons JT: Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 123:993–1005, 1993.

    Google Scholar 

  22. Lee MG, Nurse P: Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 327:31–35, 1987.

    Google Scholar 

  23. Osmani SA, Pu RT, Morris NR: Mitotic induction and maintenance by overexpression of a G2-specific gene that encodes a potential protein kinase. Cell 53:237–244, 1988.

    Google Scholar 

  24. Reed SI, Hadwiger JA, Lorincz AT: Protein kinase activity associated with the product of the yeast cell division cycle gene CDC28. Proc Natl Acad Sci USA 82:4055–4059, 1985.

    Google Scholar 

  25. Simanis V, Nurse P: The cell cycle control gene cdc2+ of fission yeast encodes a protein kinase potentially regulated by phosphorylation. Cell 45:261–268, 1986.

    Google Scholar 

  26. Celenza JL, Carlson M: A yeast gene that is essential for release from glucose repression encodes a protein kinase. Science 233:1175–1180, 1986.

    Google Scholar 

  27. Cogswell P, Morgan R, Dunn M, Neubauer A, Poland-Johnston NK, Nelson P, Sandberg AA, Liu E: Mutations of theras protooncogenes in chronic myelogenous leukemia: a high incidence ofras mutations inbcr/abl rearrangement negative chronic myelogenous leukemia. Blood 74:2629–2633, 1989.

    Google Scholar 

  28. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky M:BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175–185, 1993.

    Google Scholar 

  29. Cartwright CA, Meisler A, Eckhart W: Activation of the pp60src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 87:558–562, 1990.

    Google Scholar 

  30. Cartwright CA, Kamps MP, Meisler AI, Pipas JM, Eckhart W: c-src activation in human colon carcinoma. J Clin Invest 83:2025–2033, 1989.

    Google Scholar 

  31. Hennipman A, van-Oirschot BA, Smits J, Rijksen G, Staal GE: Tyrosine kinase activity in breast cancer, benign breast, and normal breast tissue. Cancer Res 49:516–521, 1989.

    Google Scholar 

  32. Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE: Characterization of protein tyrosine kinases from human breast cancer: involvement of thesrc oncogene product. Cancer Res 52:4773–4778, 1992.

    Google Scholar 

  33. Cance WG, Craven RJ, Bergman M, Xu LH, Alitalo K, Liu ET: Rak, a novel nuclear tyrosine kinase expressed in epithelial cells (submitted).

  34. Muller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C, et al: The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and-gamma signal transduction. Nature 366:129–135, 1993.

    Google Scholar 

  35. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 76:253–262, 1994.

    Google Scholar 

  36. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN: Involvement of the JAK-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153–157, 1994.

    Google Scholar 

  37. Weidmann E, Sacchi M, Plaisance S, Heo DS, Yasumura S, Lin WC, Johnson JT, Herberman RB, Azzarone B, Whiteside TL: Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumorin situ. Cancer Res 52:5963–5970, 1992.

    Google Scholar 

  38. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327–336, 1991.

    Google Scholar 

  39. Zachary I, Rozengert E: Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 71:891–894, 1992.

    Google Scholar 

  40. Juliano RL, Varner JA: Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5:812–818, 1993.

    Google Scholar 

  41. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL: Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 267:23439–23442, 1992.

    Google Scholar 

  42. Weiner T, Craven J, Liu ET, Cance WG: Expression of Focal Adhesion Kinase gene and invasive cancer. Lancet 342:1025–1026, 1993.

    Google Scholar 

  43. Lidereau R, Callahan R, Dickson C, Peters G, Escot C, Alki IU: Amplification of the int-2 gene in primary human breast tumors. Oncogene Res 2:285–291, 1988.

    Google Scholar 

  44. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J: Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 49: 3104–3108, 1989.

    Google Scholar 

  45. Zhou DJ, Casey G, Cline MJ: Amplification of human int-2 in breast cancers and squamous carcinomas. Oncogene 2:279–282, 1988.

    Google Scholar 

  46. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439–444, 1991.

    Google Scholar 

  47. Xiong Y, Connolly T, Futcher B, Beach D: Human Dtype cyclin. Cell 65:691–699, 1991.

    Google Scholar 

  48. Sherr CJ: The ins and outs of RB: Coupling gene expression to the cell cycle clock. Trends in Cell Biol 4:15–18, 1994.

    Google Scholar 

  49. Pines J, Hunter T: p34cdc2: the S and M kinase? New Biol 2:389–401, 1990.

    Google Scholar 

  50. Reed SI: G1 control in yeast and animal cells. Ciba Foundation Symp 170:7–15, 1992.

    Google Scholar 

  51. Ohtsubo M, Roberts JM: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908–1912, 1993.

    Google Scholar 

  52. Xiong Y, personal communication.

  53. el Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825, 1993.

    Google Scholar 

  54. Levedakou E, He M, Baptist E, Craven R, Cance W, Welcsh P, Simmons A, Naylor S, Leach R, Lewis T, Bowcock A, Liu E: Two novel human serine/threonine kinases with homologies to the cell cycle regulating Xenopus M015, and NIMA kinases: cloning and characterization of their expression pattern. Oncogene 9:1977–1988, 1994.

    Google Scholar 

  55. Augustine K, Liu ET, Sadler T: Antisense inhibition of wnt-1 expression in mouse embryos results in hindbrain, cardiac, and facial abnormalities. Developmental Genetics 14:500–520, 1993.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cance, W.G., Liu, E.T. Protein kinases in human breast cancer. Breast Cancer Res Tr 35, 105–114 (1995). https://doi.org/10.1007/BF00694751

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00694751

Key words

  • breast cancer
  • focal adhesion kinase
  • HER-2
  • novel genes
  • protein kinases
  • tyrosine kinases